Keyphrases
Estrogen Receptor
100%
Extracellular Matrix Organization
100%
Breast Cancer
100%
Cancer Modeling
100%
Collagen I
75%
Receptor Cells
50%
Extracellular Matrix
37%
Tumor Extracellular Matrix
37%
Progesterone Receptor
25%
Resistance to Therapy
25%
Triple-negative Breast Cancer
25%
Breast Cancer Subtypes
25%
Collagen Content
25%
Multidrug-resistant
12%
Fibronectin
12%
Chemotherapy
12%
Enhanced Expression
12%
Cell Culture
12%
Tumor
12%
Disease Progression
12%
Collagen
12%
In Vivo Analysis
12%
Stiffness
12%
Pathway Activation
12%
Binding Affinity
12%
Immunohistochemical Analysis
12%
Tumor Progression
12%
Matrigel
12%
MDA-MB-231 Cells
12%
Collagen IV
12%
Breast Tumor
12%
Three Dimensional Model
12%
Laboratory Setting
12%
In Vitro Model
12%
Targeted Therapy
12%
Physiologically Relevant
12%
Resistance Development
12%
Oncogenic Pathways
12%
Cellular Survival
12%
Senescence-associated
12%
Patient Tumor
12%
Subtype-specific
12%
Therapeutic Regimen
12%
Cell Microenvironment
12%
Estrogen Receptor-positive
12%
Laminin
12%
In Vitro Tumor Models
12%
Translational Model
12%
Oncology Drugs
12%
Content-based
12%
Cellular Phenotype
12%
Cellular Elasticity
12%
Complex Matrices
12%
Matrix Composites
12%
Tumor Samples
12%
Resistance Acquisition
12%
Estrogen Receptor-negative
12%
Primary Current
12%
Response to Therapy
12%
Matrix Composition
12%
Medicine and Dentistry
Extracellular Matrix
100%
Breast Cancer
100%
Estrogen Receptor
100%
Neoplasm
40%
In Vitro
30%
Cell Line
20%
Triple Negative Breast Cancer
20%
Progesterone Receptor
20%
Disease Exacerbation
10%
Receptor
10%
Tumor Progression
10%
Oncology
10%
Cancer
10%
Prevalence
10%
Fibronectin
10%
Immunohistochemistry
10%
Cell Proliferation
10%
Matrigel
10%
Binding Affinity
10%
Carcinogenesis
10%
Targeted Therapy
10%
Breast Tumor
10%
Tumor Model
10%
Collagen Fibril
10%
Laminin
10%
Tumor
10%
Pharmacology, Toxicology and Pharmaceutical Science
Estrogen Receptor
100%
Breast Cancer
100%
Neoplasm
40%
Progesterone Receptor
20%
Triple Negative Breast Cancer
20%
Receptor
10%
Fibronectin
10%
Tumor Growth
10%
Chemotherapy
10%
Carcinogenesis
10%
Prevalence
10%
Disease Exacerbation
10%
Matrigel
10%
Breast Tumor
10%
Tumor Model
10%
Laminin
10%
Biochemistry, Genetics and Molecular Biology
Estrogen Receptor
100%
Progesterone Receptor
20%
Cell Proliferation
10%
Transcription
10%
Prevalence
10%
Tumor Progression
10%
Laminin
10%
Binding Affinity
10%
Carcinogenesis
10%
Rigidity
10%
Fibronectin
10%
Targeted Therapy
10%